MEDIFAST INC MED
NYSE · XNYS · stock · Miscellaneous Food Preparations & Kindred Products
Chart by TradingView
3/9
Piotroski F — financial health
10.15
Altman Z″ — distress risk · safe
-1.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $385.8M | -$18.7M | $275.2M | $1.2M | $198.9M |
| 2024 | $602.5M | $2.1M | $444.6M | $17.0M | $210.1M |
| 2023 | $1.1B | $99.4M | $775.9M | $141.2M | $201.5M |
| 2022 | $1.6B | $143.6M | $1.1B | $177.9M | $155.0M |
| 2021 | $1.5B | $164.0M | $1.1B | $60.3M | $202.5M |
| 2020 | $934.8M | $102.9M | $697.8M | $139.3M | $157.2M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Rose Jeffrey Matthew | director | 2026-05-26 | Grant | 11,680 | — |
| Kiai Parsa | director | 2026-05-26 | Grant | 11,680 | — |
| Rose Jeffrey Matthew | director | 2026-05-26 | Grant | 6,739 | — |
| Thomas Andrea B | director | 2026-05-26 | Grant | 11,680 | — |
| SCHLACKMAN SCOTT | director | 2026-05-26 | Grant | 11,680 | — |
| Geary Elizabeth A. | director | 2026-05-26 | Grant | 11,680 | — |
| Kiai Parsa | director | 2026-05-26 | Grant | 7,637 | — |
| SCHLACKMAN SCOTT | director | 2026-05-11 | Buy | 2,500 | $12.53 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 10.15 (safe)
- Working capital / assets 0.64
- Retained earnings / assets 0.638
- EBIT / assets -0.057
- Equity / liabilities 4.055
Source: SEC EDGAR filings · CIK 0000910329 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.